Home >Products> Bio Service >Bio Service> Recombinant carboxypeptidase B CAS 80651-95-2
Bio Service:  Bio Service  
Recombinant carboxypeptidase B CAS 80651-95-2
Place of Origin:
China
Brand:
Putai bio
Model:
Price:
Hits:
366 
Updated:
2/24/2021
  • Product Detail
  • Company Profile

    Recombinant carboxypeptidase B  80651-95-2

     

    I. Product introduction

    Carboxypeptidase B (EC 3.4.17.2) is an exocrine protease belonging to the family of metal carboxypeptidase A and carboxypeptidase B (CPA/CPB). It contains one Zn atom per molecule. It can specifically hydrolyze the peptide bond at the amino terminal of the C-terminal basic amino acids of proteins (Lysine, Arginine, Histidine).

    This product is a lyophilized powder which is expressed by recombinant Yeast, freeze-dried after multi-step separation and purification. It is homologous to porcine carboxypeptidase B and also has the same specificity and activity consistent with it. However, the product is free of Animal viruses and other hybrid enzymes and can be used as an alternative to animal-derived carboxypeptidase B for various biotechnological processes.The activity of recombinant carboxypeptidase B was inhibited by typical metal chelating agents such as EDTA, Cu2+, Hg2+, Zn2+, Mn2+ and so on.The optimal pH of CPB is 8.0, and both partial acid and partial base will lead to decreased activity. The activity is close to zero when the pH is close to 5.0, and the activity is completely lost when the pH is close to 12.0.carboxypeptidase B activity increased with the increase of temperature at a certain temperature (<60℃)

     

    II. Product characteristics

    Source: Pichia pastoris

    Character: White or off-white lyophilized powder

    Purity (SDS-PAGE): single main band

    Specific activity: ≥100U /mg pro

    Specificity: hydrolyzed protein c-terminal basic amino acids (lysine, arginine, histidine)

     

    III. Product use

    Recombinant carboxypeptidase B can be used for the production of insulin and analogs, the quality testing of recombinant antibodies, the determination of protein C-terminal amino acids, the production of small molecular proteins or peptides, such as cosmetic peptides, antimicrobial peptides, food flavor peptides, etc. And enzymatic synthesis of certain specific compounds..

     

    Iv. Recommend Usage

    It is recommended to dissolve the recombinant carboxypeptidase B lyophilized powder with 25 mM Tris-HCl (pH 7.6) to make the concentration of the enzyme solution 1-10 mg/ml. the amount of enzyme: the target protein (mass ratio) = 1:50-1:1000, the reaction pH is 7.5-9.0 and temperature is 25-35°C.

     

    V. Storage stability

    Store at -15℃~-20℃, stable within 24 months; when Tris-HCl buffer is formulated into an enzyme solution, repeatedly frozen and thawed 5 times, no loss of activity.

     

    Vi. Product advantages

    Animal origin free: Recombinant production, no exogenous virus contamination. No animal-derived material is used during production.

    Stable quality: stable and continuous batch production can be guaranteed; T here is no difference between product batches and the quality is stable. High purity: no any other contaminated proteases, non- specific cutting sites.

    Compliance with regulatory requirements: The production equipment and production environment comply with relevant regulatory requirements, and the production process is in full compliance with the NSF ISO 9001:2015 quality system and in accordance with GMP guidelines.

    Complete quality documentation: Relevant regulatory support documents are available upon request.

    Provide residue detection services.

    bio-equip.cn
    Hangzhou Putai Biotechnology Co., Ltd., located in Xuxian Industrial Park, Xiaoshan, Hangzhou, is a new high-tech enterprise established in 2018. The company takes "using genetic engineering technology to accelerate the development of innovative pharmaceutical products" as its business mission, and "customer-centric, integrity as the cornerstone, quality as the fundamental" as its core values.

    In 2011, the founding shareholder of Putai bio established health path Pharma Co., Ltd., a manufacturing enterprise in Cambodia, which is now one of the most important pharmaceutical companies in Cambodia. On the one hand, Putai biology is a pilot research and development base of health path Pharma in China, on the other hand, it will provide various gene recombination products and technical services for domestic and foreign counterparts.

    At present, the products of Putai bio have been developed and put into production include: recombinant trypsin, recombinant enterokinase, recombinant lysine endonuclease, recombinant carboxypeptidase B and other enzyme products; recombinant GM-CSF, recombinant G-CSF, recombinant interferon and other cytokine products.

    Putai biology has a complete R & D, production and quality management system. The company has more than tons of fermentation tanks and supporting separation, purification, verification and other equipment and facilities, which can meet the needs of industrial customers.

    At present, Putai biology has carried out scientific research cooperation and personnel training with Zhejiang University, Zhejiang University of science and technology, Zhejiang University of science and technology and other universities, and is committed to building an excellent scientific research and development team, contributing to the development of biological pharmaceutical industry at home and abroad.
Request Information
Request Information: yes no
Request Quotation: yes no
refresh

I agree to share my inquiry with the other matching suppliers.

Request Information

* Name:
Job Title:
* Tel:
Fax:
* E-mail:
Postcode:
Institution/Company:
Address:
* Country:
Request Information:
yes no
Request Quotation:
yes no
* Message:
* Verification Code:
refresh
I agree to share my inquiry to the other matching suppliers.